Gardasil 9 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FVYH6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,920
Award facts
- Contract value 100% obligated
- $10,919.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) for $10,919.54 on January 14, 2026, with completion scheduled for January 15, 2026. The contract covers the supply of GARDASIL 9 vaccine in 0.5mL syringes and is structured as a firm fixed-price delivery order with no set-aside designation. The place of performance is Conshohocken, Pennsylvania, the location of Amerisourcebergen's corporate office. This delivery order is executed under a larger Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Amerisourcebergen Drug Corp maintains a significant role in federal pharmaceutical procurement as a critical vendor for the Department of Defense medical supply chain. The parent company, Cencora, Inc., holds the primary IDC with DLA and demonstrates extensive experience fulfilling federal medical commodity requirements across multiple therapeutic domains. This award reflects the company's capability to competitively deliver essential vaccines and pharmaceutical products to support military healthcare systems. The rapid completion timeline indicates the urgent nature of this particular vaccine delivery to support Defense Health Agency and broader military medical operations.
Quick answers
Who was awarded contract SPE2DR26FVYH6?
SPE2DR26FVYH6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FVYH6 worth?
The government has obligated $10,920 on SPE2DR26FVYH6.
Is contract SPE2DR26FVYH6 an order under another contract?
Yes. SPE2DR26FVYH6 is a delivery order under SPE2DR25D3002, an indefinite delivery contract.
Was contract SPE2DR26FVYH6 competed?
The extent of competition for SPE2DR26FVYH6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award